Literature DB >> 10525521

A new mutation of the cardiac troponin T gene causing familial hypertrophic cardiomyopathy without left ventricular hypertrophy.

A Varnava1, C Baboonian, F Davison, L de Cruz, P M Elliott, M J Davies, W J McKenna.   

Abstract

AIM: To screen for a mutation of the cardiac troponin T gene in two families where there had been sudden deaths without an increase in left ventricular mass but with myocardial disarray suggesting hypertrophic cardiomyopathy.
METHODS: DNA from affected individuals from both families was used to screen the cardiac troponin T gene on an exon by exon basis. Mutation screening was achieved by polymerase chain reaction and direct sequencing. Where appropriate, a mutation was confirmed by restriction digest.
RESULTS: A novel missense mutation of exon 9 was found in the affected individuals of one of the families. This mutation at amino acid 94 resulted in the substitution of arginine for leucine and was not found in 100 normal control samples. A mutation of the cardiac troponin T gene was excluded in the second family.
CONCLUSIONS: A mutation of the gene for the sarcomeric protein cardiac troponin T can cause familial hypertrophic cardiomyopathy with marked myocyte disarray and frequent premature sudden death in the absence of myocardial hypertrophy at clinical or macroscopic level.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10525521      PMCID: PMC1760789          DOI: 10.1136/hrt.82.5.621

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  17 in total

1.  A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.

Authors:  A A Geisterfer-Lowrance; S Kass; G Tanigawa; H P Vosberg; W McKenna; C E Seidman; J G Seidman
Journal:  Cell       Date:  1990-09-07       Impact factor: 41.582

Review 2.  Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

Authors:  B J Maron; R O Bonow; R O Cannon; M B Leon; S E Epstein
Journal:  N Engl J Med       Date:  1987-03-26       Impact factor: 91.245

3.  Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.

Authors:  E B Lankford; N D Epstein; L Fananapazir; H L Sweeney
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

4.  Sudden death due to troponin T mutations.

Authors:  J C Moolman; V A Corfield; B Posen; K Ngumbela; C Seidman; P A Brink; H Watkins
Journal:  J Am Coll Cardiol       Date:  1997-03-01       Impact factor: 24.094

5.  Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy.

Authors:  A Kimura; H Harada; J E Park; H Nishi; M Satoh; M Takahashi; S Hiroi; T Sasaoka; N Ohbuchi; T Nakamura; T Koyanagi; T H Hwang; J A Choo; K S Chung; A Hasegawa; R Nagai; O Okazaki; H Nakamura; M Matsuzaki; T Sakamoto; H Toshima; Y Koga; T Imaizumi; T Sasazuki
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

6.  Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass.

Authors:  W J McKenna; J T Stewart; P Nihoyannopoulos; F McGinty; M J Davies
Journal:  Br Heart J       Date:  1990-05

7.  Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.

Authors:  L Thierfelder; H Watkins; C MacRae; R Lamas; W McKenna; H P Vosberg; J G Seidman; C E Seidman
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

8.  Accumulation and assembly of myosin in hypertrophic cardiomyopathy with the 403 Arg to Gln beta-myosin heavy chain mutation.

Authors:  T Vybiral; P R Deitiker; R Roberts; H F Epstein
Journal:  Circ Res       Date:  1992-12       Impact factor: 17.367

9.  Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.

Authors:  G Cuda; L Fananapazir; W S Zhu; J R Sellers; N D Epstein
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Mutations in the cardiac myosin binding protein-C gene on chromosome 11 cause familial hypertrophic cardiomyopathy.

Authors:  H Watkins; D Conner; L Thierfelder; J A Jarcho; C MacRae; W J McKenna; B J Maron; J G Seidman; C E Seidman
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

View more
  20 in total

1.  Disease-causing mutations in cardiac troponin T: identification of a critical tropomyosin-binding region.

Authors:  T Palm; S Graboski; S E Hitchcock-DeGregori; N J Greenfield
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

2.  Mutations in TNNT3 cause multiple congenital contractures: a second locus for distal arthrogryposis type 2B.

Authors:  Sandy S Sung; Anna-Marie E Brassington; Patrycja A Krakowiak; John C Carey; Lynn B Jorde; Michael Bamshad
Journal:  Am J Hum Genet       Date:  2003-07       Impact factor: 11.025

3.  The Brazilian Society of Cardiology and Brazilian Society of Exercise and Sports Medicine Updated Guidelines for Sports and Exercise Cardiology - 2019.

Authors:  Nabil Ghorayeb; Ricardo Stein; Daniel Jogaib Daher; Anderson Donelli da Silveira; Luiz Eduardo Fonteles Ritt; Daniel Fernando Pellegrino Dos Santos; Ana Paula Rennó Sierra; Artur Haddad Herdy; Claúdio Gil Soares de Araújo; Cléa Simone Sabino de Souza Colombo; Daniel Arkader Kopiler; Filipe Ferrari Ribeiro de Lacerda; José Kawazoe Lazzoli; Luciana Diniz Nagem Janot de Matos; Marcelo Bichels Leitão; Ricardo Contesini Francisco; Rodrigo Otávio Bougleux Alô; Sérgio Timerman; Tales de Carvalho; Thiago Ghorayeb Garcia
Journal:  Arq Bras Cardiol       Date:  2019-03       Impact factor: 2.000

Review 4.  Linking myofilaments to sudden cardiac death: recent advances.

Authors:  Sabine Huke
Journal:  J Physiol       Date:  2017-03-16       Impact factor: 5.182

Review 5.  Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.

Authors:  Andrew P Landstrom; Michael J Ackerman
Journal:  Circulation       Date:  2010-12-07       Impact factor: 29.690

Review 6.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

Review 7.  Increased myofilament Ca2+-sensitivity and arrhythmia susceptibility.

Authors:  Sabine Huke; Björn C Knollmann
Journal:  J Mol Cell Cardiol       Date:  2010-01-22       Impact factor: 5.000

8.  Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience.

Authors:  P Charron; D Héron; M Gargiulo; P Richard; O Dubourg; M Desnos; J B Bouhour; J Feingold; L Carrier; B Hainque; K Schwartz; M Komajda
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

Review 9.  TNNT1, TNNT2, and TNNT3: Isoform genes, regulation, and structure-function relationships.

Authors:  Bin Wei; J-P Jin
Journal:  Gene       Date:  2016-01-13       Impact factor: 3.688

10.  Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cardiomyopathy.

Authors:  Ingegerd Ostman-Smith; Aase Wisten; Eva Nylander; Ewa-Lena Bratt; Anne de-Wahl Granelli; Abderrahim Oulhaj; Erik Ljungström
Journal:  Eur Heart J       Date:  2009-11-05       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.